Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists discover genetic pathway responsible for breast cancer cell growth

09.08.2005


Scientists at the MUHC have made an important discovery that will advance our understanding of how the female hormone estrogen causes growth of breast cancer cells. The research, in collaboration with scientists at the Institut de Recherches Cliniques de Montreal (IRCM) identifies 153 genes that respond to estrogen and one in particular that can be used to halt the growth of breast cancer cells. The study, published in today’s Proceedings of the National Academy of Sciences (PNAS), will focus future research for a breast cancer cure.

"We have known for a very long time that estrogen causes the growth of breast cancer cells," says lead investigator Dr. Vincent Giguère. "This is how oncologists came to use anti-estrogen as drugs to combat the most common forms of breast cancer." What has remained a mystery however, is the molecular mechanism by which estrogen makes breast cancer cells grow. "Until this is solved, we will be no closer to figuring out how to prevent and cure breast cancer," Dr. Giguère noted.

Over the past two decades researchers have identified around 20 estrogen-activated genes that play a role in development of breast cancer. "That’s about one gene discovery per year," says Dr. Giguère. "Using cutting edge new technology derived directly from the human genome project, this study adds over hundred additional genes to this total."



The technology used information obtained from the human genome project to create a new type of DNA microchip containing the partial DNA sequences of approximately 19,000 genes. Dr. Giguère’s team was able to localize where the estrogen receptor was bound in the genome of breast cancer cells, thereby identifying a large number of genes that respond to this hormone in a single experiment. "This technology, first developed for the study of yeast, now offers the opportunity to rapidly identify, in a genome-wide manner, the genes involved in the response to natural hormones or drugs in normal and cancer cells," says co-author Dr. François Robert from the IRCM.

Of particular importance was the discovery of a gene called FOXA1, known as a transcription factor. "FOXA1 can be viewed as a facilitator of estrogen action on cancer cells," says Josée Laganière, a graduate student at the MUHC and principal author of the paper. "It is found in breast cancer tumours that express the estrogen receptor." In their study, the researchers found that the FOXA1 gene was required for the estrogen receptor to activate the growth of breast cancer cells.

"By inactivating the FOXA1 gene in laboratory cell cultures, we were able to block the growth-inducing effect of estogen, and thus halt the growth of breast cancer cells," says Dr. Giguère. In FOXA1 researchers have found a new target that affects the development of breast cancer. In practical terms, efforts can now be focused on developing a more precise cure/treatment for cancer based on this gene. "The problem with cancer drugs in general has been that they are often untargeted, which is why patients experience side effects," notes Dr. Giguère. "The more focused the drugs the less side effects and the more chance you have to cure the disease."

"Research targeting individual molecules associated with pathogenesis of cancer has led to positive clinical results," says Dr. Joseph Ragaz, Director of MUHC Oncology Program. "Evidence-based data on agents such as Gleevac in leukemia, Avastin in colorectal cancer, and more recently with Herceptin for breast cancer, confirm that the efforts of researchers like Dr. Giguere and his team save lives and money. These connections between research and health care are one of the strengths of academic hospitals like the MUHC."

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge.

The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University--the Montreal Children’s, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge.

Ian Popple | MUHC PR and Commun
Further information:
http://www.muhc.ca/research

More articles from Life Sciences:

nachricht Are there sustainable solutions in dealing with dwindling phosphorus resources?
16.10.2017 | Leibniz-Institut für Nutzierbiologie (FBN)

nachricht Strange undertakings: ant queens bury dead to prevent disease
13.10.2017 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

Im Focus: New nanomaterial can extract hydrogen fuel from seawater

Hybrid material converts more sunlight and can weather seawater's harsh conditions

It's possible to produce hydrogen to power fuel cells by extracting the gas from seawater, but the electricity required to do it makes the process costly. UCF...

Im Focus: Small collisions make big impact on Mercury's thin atmosphere

Mercury, our smallest planetary neighbor, has very little to call an atmosphere, but it does have a strange weather pattern: morning micro-meteor showers.

Recent modeling along with previously published results from NASA's MESSENGER spacecraft -- short for Mercury Surface, Space Environment, Geochemistry and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

Conference Week RRR2017 on Renewable Resources from Wet and Rewetted Peatlands

28.09.2017 | Event News

 
Latest News

A single photon reveals quantum entanglement of 16 million atoms

16.10.2017 | Physics and Astronomy

The melting ice makes the sea around Greenland less saline

16.10.2017 | Earth Sciences

On the generation of solar spicules and Alfvenic waves

16.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>